Morgan Stanley’s Prenetics Global PRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Buy
23,443
+6,350
+37% +$117K ﹤0.01% 5598
2026
Q1
$330K Sell
17,093
-6,706
-28% -$125K ﹤0.01% 5674
2025
Q4
$375K Buy
23,799
+13,975
+142% +$204K ﹤0.01% 5660
2025
Q3
$131K Buy
9,824
+900
+10% +$7.89K ﹤0.01% 6044
2025
Q2
$76K Buy
8,924
+6,800
+320% +$43.9K ﹤0.01% 6223
2025
Q1
$8.33K Hold
2,124
﹤0.01% 6853
2024
Q4
$12.3K Sell
2,124
-250
-11% -$1.21K ﹤0.01% 6732
2024
Q3
$9.5K Buy
+2,374
New +$12.4K ﹤0.01% 6731

Other funds holding PRE

Morgan Stanley's PRE Position: Q2 2026 in Review

Morgan Stanley increased its Prenetics Global (PRE) stake by 37% in Q2 2026, buying an estimated $117K and bringing the position to 23,443 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #5598.

Morgan Stanley first reported a position in PRE in Q3 2024 and has held it in 8 quarters since. 25 funds tracked by Wall St. Rank hold PRE as of Q2 2026.

  • Morgan Stanley held 23,443 shares of Prenetics Global worth $448K as of Q2 2026.
  • Morgan Stanley bought 6,350 Prenetics Global shares in Q2 2026, an estimated $117K.
  • Prenetics Global made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5598 holding.
  • Morgan Stanley first reported a position in Prenetics Global in Q3 2024 and has held it in 8 quarters since.
  • 25 funds tracked by Wall St. Rank held Prenetics Global as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.